ABBV-119

N/A

Report date: 2023/06/23 20:01:31

NME

Base Information

Drug NameABBV-119

Drug Alias NameABBV-119

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators

TargetsCystic fibrosis transmembrane conductance regulator

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited StatesSlovakia +[7]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAbbvie Inc

Active IndicationsN/A

Inactive IndicationsCystic Fibrosis

ATC CodeN/A